Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil(Centre National de la Recherche Scientifique), Olivier Hermine(Délégation Paris 5)
Cited by 409
Related Papers
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
|The Journal of Experimental Medicine|2010|194
Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
|PLoS ONE|2010|75
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
|Nature Communications|2017|24